Global Human Vaccines Market Research Report 2017

ヒトワクチンの世界市場

◆タイトル:Global Human Vaccines Market Research Report 2017
◆商品コード:QYR70902629
◆調査・発行会社:QYResearch
◆発行日:2017年8月22日
◆ページ数:118
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥319,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥638,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

QYResearchが発行した当調査レポートでは、世界のヒトワクチン市場について調査・分析し、ヒトワクチンの世界市場概観、ヒトワクチンの種類別市場分析、用途別市場分析、ヒトワクチンの世界市場規模予測、関連企業分析、主要地域別分析(北米市場、ヨーロッパ市場、中国市場、日本市場、アジア市場など)、関連企業情報、価格情報、販売動向、市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・ヒトワクチンの世界市場概観
・ヒトワクチンの種類別市場規模
・ヒトワクチンの用途別市場規模
・ヒトワクチンの世界市場規模
・ヒトワクチンの世界市場規模予測
・ヒトワクチンの主要地域別市場規模
・ヒトワクチンの北米市場規模・予測
・ヒトワクチンのヨーロッパ市場規模・予測
・ヒトワクチンの中国市場規模・予測
・ヒトワクチンの日本市場規模・予測
・ヒトワクチンのアジア市場規模・予測
・ヒトワクチンの製造メーカー分析
・ヒトワクチンのメーカー別生産量
・ヒトワクチンのメーカー別市場シェア
・ヒトワクチンの価格動向・価格分析
・ヒトワクチンの販売(売上高)動向
・ヒトワクチンの貿易(輸出・輸入)動向
・ヒトワクチンの産業チェーン分析
・ヒトワクチンのマーケティング戦略分析
・ヒトワクチンの販売業者(代理店)リスト
・ヒトワクチンの市場環境分析
...

In this report, the global Human Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Human Vaccines in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Human Vaccines market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
AstraZeneca
Bavarian Nordic
Bharat Biotech
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
Merck & Co., Inc.
Mymetics
Novartis AG
Pfizer, Inc.
Sanofi
Shenzhen Kangtai Biological Products Co., Ltd.
Takeda Pharmaceutical Company Limited.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Pneumococcal
Influenza
Hepatitis
HPV
Meningococcal
Rotavirus
Measles
Typhoid
Combination
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Human Vaccines for each application, including
Pediatrics
Adolescents
Adults
Geriatrics

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Human Vaccines Market Research Report 2017
1 Human Vaccines Market Overview
1.1 Product Overview and Scope of Human Vaccines
1.2 Human Vaccines Segment by Type (Product Category)
1.2.1 Global Human Vaccines Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Human Vaccines Production Market Share by Type (Product Category) in 2016
1.2.3 Pneumococcal
1.2.4 Influenza
1.2.5 Hepatitis
1.2.6 HPV
1.2.7 Meningococcal
1.2.8 Rotavirus
1.2.9 Measles
1.2.10 Typhoid
1.2.11 Combination
1.3 Global Human Vaccines Segment by Application
1.3.1 Human Vaccines Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Pediatrics
1.3.3 Adolescents
1.3.4 Adults
1.3.5 Geriatrics
1.4 Global Human Vaccines Market by Region (2012-2022)
1.4.1 Global Human Vaccines Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Human Vaccines (2012-2022)
1.5.1 Global Human Vaccines Revenue Status and Outlook (2012-2022)
1.5.2 Global Human Vaccines Capacity, Production Status and Outlook (2012-2022)

2 Global Human Vaccines Market Competition by Manufacturers
2.1 Global Human Vaccines Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Human Vaccines Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Human Vaccines Production and Share by Manufacturers (2012-2017)
2.2 Global Human Vaccines Revenue and Share by Manufacturers (2012-2017)
2.3 Global Human Vaccines Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Human Vaccines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Human Vaccines Market Competitive Situation and Trends
2.5.1 Human Vaccines Market Concentration Rate
2.5.2 Human Vaccines Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Human Vaccines Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Human Vaccines Capacity and Market Share by Region (2012-2017)
3.2 Global Human Vaccines Production and Market Share by Region (2012-2017)
3.3 Global Human Vaccines Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Human Vaccines Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Human Vaccines Consumption by Region (2012-2017)
4.2 North America Human Vaccines Production, Consumption, Export, Import (2012-2017)
4.3 Europe Human Vaccines Production, Consumption, Export, Import (2012-2017)
4.4 China Human Vaccines Production, Consumption, Export, Import (2012-2017)
4.5 Japan Human Vaccines Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Human Vaccines Production, Consumption, Export, Import (2012-2017)
4.7 India Human Vaccines Production, Consumption, Export, Import (2012-2017)

5 Global Human Vaccines Production, Revenue (Value), Price Trend by Type
5.1 Global Human Vaccines Production and Market Share by Type (2012-2017)
5.2 Global Human Vaccines Revenue and Market Share by Type (2012-2017)
5.3 Global Human Vaccines Price by Type (2012-2017)
5.4 Global Human Vaccines Production Growth by Type (2012-2017)

6 Global Human Vaccines Market Analysis by Application
6.1 Global Human Vaccines Consumption and Market Share by Application (2012-2017)
6.2 Global Human Vaccines Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Human Vaccines Manufacturers Profiles/Analysis
7.1 AstraZeneca
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Human Vaccines Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AstraZeneca Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Bavarian Nordic
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Human Vaccines Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bavarian Nordic Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Bharat Biotech
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Human Vaccines Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bharat Biotech Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 CSL Limited
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Human Vaccines Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 CSL Limited Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Emergent BioSolutions, Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Human Vaccines Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Emergent BioSolutions, Inc. Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline plc
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Human Vaccines Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 GlaxoSmithKline plc Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Johnson & Johnson
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Human Vaccines Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Johnson & Johnson Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Merck & Co., Inc.
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Human Vaccines Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Merck & Co., Inc. Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Mymetics
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Human Vaccines Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Mymetics Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Novartis AG
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Human Vaccines Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Novartis AG Human Vaccines Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Pfizer, Inc.
7.12 Sanofi
7.13 Shenzhen Kangtai Biological Products Co., Ltd.
7.14 Takeda Pharmaceutical Company Limited.

8 Human Vaccines Manufacturing Cost Analysis
8.1 Human Vaccines Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Human Vaccines

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Human Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Human Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Human Vaccines Market Forecast (2017-2022)
12.1 Global Human Vaccines Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Human Vaccines Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Human Vaccines Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Human Vaccines Price and Trend Forecast (2017-2022)
12.2 Global Human Vaccines Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Human Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Human Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Human Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Human Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Human Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Human Vaccines Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Human Vaccines Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Human Vaccines Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer

List of Tables and Figures

Figure Picture of Human Vaccines
Figure Global Human Vaccines Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Human Vaccines Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Pneumococcal
Table Major Manufacturers of Pneumococcal
Figure Product Picture of Influenza
Table Major Manufacturers of Influenza
Figure Product Picture of Hepatitis
Table Major Manufacturers of Hepatitis
Figure Product Picture of HPV
Table Major Manufacturers of HPV
Figure Product Picture of Meningococcal
Table Major Manufacturers of Meningococcal
Figure Product Picture of Rotavirus
Table Major Manufacturers of Rotavirus
Figure Product Picture of Measles
Table Major Manufacturers of Measles
Figure Product Picture of Typhoid
Table Major Manufacturers of Typhoid
Figure Product Picture of Combination
Table Major Manufacturers of Combination
Figure Global Human Vaccines Consumption (K Units) by Applications (2012-2022)
Figure Global Human Vaccines Consumption Market Share by Applications in 2016
Figure Pediatrics Examples
Figure Adolescents Examples
Figure Adults Examples
Figure Geriatrics Examples
Figure Global Human Vaccines Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Human Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Human Vaccines Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Human Vaccines Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Human Vaccines Major Players Product Capacity (K Units) (2012-2017)
Table Global Human Vaccines Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Human Vaccines Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Human Vaccines Capacity (K Units) of Key Manufacturers in 2016
Figure Global Human Vaccines Capacity (K Units) of Key Manufacturers in 2017
Figure Global Human Vaccines Major Players Product Production (K Units) (2012-2017)
Table Global Human Vaccines Production (K Units) of Key Manufacturers (2012-2017)
Table Global Human Vaccines Production Share by Manufacturers (2012-2017)
Figure 2016 Human Vaccines Production Share by Manufacturers
Figure 2017 Human Vaccines Production Share by Manufacturers
Figure Global Human Vaccines Major Players Product Revenue (Million USD) (2012-2017)
Table Global Human Vaccines Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Human Vaccines Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Human Vaccines Revenue Share by Manufacturers
Table 2017 Global Human Vaccines Revenue Share by Manufacturers
Table Global Market Human Vaccines Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Human Vaccines Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Human Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Human Vaccines Product Category
Figure Human Vaccines Market Share of Top 3 Manufacturers
Figure Human Vaccines Market Share of Top 5 Manufacturers
Table Global Human Vaccines Capacity (K Units) by Region (2012-2017)
Figure Global Human Vaccines Capacity Market Share by Region (2012-2017)
Figure Global Human Vaccines Capacity Market Share by Region (2012-2017)
Figure 2016 Global Human Vaccines Capacity Market Share by Region
Table Global Human Vaccines Production by Region (2012-2017)
Figure Global Human Vaccines Production (K Units) by Region (2012-2017)
Figure Global Human Vaccines Production Market Share by Region (2012-2017)
Figure 2016 Global Human Vaccines Production Market Share by Region
Table Global Human Vaccines Revenue (Million USD) by Region (2012-2017)
Table Global Human Vaccines Revenue Market Share by Region (2012-2017)
Figure Global Human Vaccines Revenue Market Share by Region (2012-2017)
Table 2016 Global Human Vaccines Revenue Market Share by Region
Figure Global Human Vaccines Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Human Vaccines Consumption (K Units) Market by Region (2012-2017)
Table Global Human Vaccines Consumption Market Share by Region (2012-2017)
Figure Global Human Vaccines Consumption Market Share by Region (2012-2017)
Figure 2016 Global Human Vaccines Consumption (K Units) Market Share by Region
Table North America Human Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Human Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Human Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Human Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Human Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Human Vaccines Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Human Vaccines Production (K Units) by Type (2012-2017)
Table Global Human Vaccines Production Share by Type (2012-2017)
Figure Production Market Share of Human Vaccines by Type (2012-2017)
Figure 2016 Production Market Share of Human Vaccines by Type
Table Global Human Vaccines Revenue (Million USD) by Type (2012-2017)
Table Global Human Vaccines Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Human Vaccines by Type (2012-2017)
Figure 2016 Revenue Market Share of Human Vaccines by Type
Table Global Human Vaccines Price (USD/Unit) by Type (2012-2017)
Figure Global Human Vaccines Production Growth by Type (2012-2017)
Table Global Human Vaccines Consumption (K Units) by Application (2012-2017)
Table Global Human Vaccines Consumption Market Share by Application (2012-2017)
Figure Global Human Vaccines Consumption Market Share by Applications (2012-2017)
Figure Global Human Vaccines Consumption Market Share by Application in 2016
Table Global Human Vaccines Consumption Growth Rate by Application (2012-2017)
Figure Global Human Vaccines Consumption Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Human Vaccines Production Growth Rate (2012-2017)
Figure AstraZeneca Human Vaccines Production Market Share (2012-2017)
Figure AstraZeneca Human Vaccines Revenue Market Share (2012-2017)
Table Bavarian Nordic Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bavarian Nordic Human Vaccines Production Growth Rate (2012-2017)
Figure Bavarian Nordic Human Vaccines Production Market Share (2012-2017)
Figure Bavarian Nordic Human Vaccines Revenue Market Share (2012-2017)
Table Bharat Biotech Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bharat Biotech Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bharat Biotech Human Vaccines Production Growth Rate (2012-2017)
Figure Bharat Biotech Human Vaccines Production Market Share (2012-2017)
Figure Bharat Biotech Human Vaccines Revenue Market Share (2012-2017)
Table CSL Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Limited Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CSL Limited Human Vaccines Production Growth Rate (2012-2017)
Figure CSL Limited Human Vaccines Production Market Share (2012-2017)
Figure CSL Limited Human Vaccines Revenue Market Share (2012-2017)
Table Emergent BioSolutions, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent BioSolutions, Inc. Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Production Growth Rate (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Production Market Share (2012-2017)
Figure Emergent BioSolutions, Inc. Human Vaccines Revenue Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline plc Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Production Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Production Market Share (2012-2017)
Figure GlaxoSmithKline plc Human Vaccines Revenue Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Human Vaccines Production Growth Rate (2012-2017)
Figure Johnson & Johnson Human Vaccines Production Market Share (2012-2017)
Figure Johnson & Johnson Human Vaccines Revenue Market Share (2012-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Production Growth Rate (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Production Market Share (2012-2017)
Figure Merck & Co., Inc. Human Vaccines Revenue Market Share (2012-2017)
Table Mymetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mymetics Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mymetics Human Vaccines Production Growth Rate (2012-2017)
Figure Mymetics Human Vaccines Production Market Share (2012-2017)
Figure Mymetics Human Vaccines Revenue Market Share (2012-2017)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Human Vaccines Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Human Vaccines Production Growth Rate (2012-2017)
Figure Novartis AG Human Vaccines Production Market Share (2012-2017)
Figure Novartis AG Human Vaccines Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human Vaccines
Figure Manufacturing Process Analysis of Human Vaccines
Figure Human Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Human Vaccines Major Manufacturers in 2016
Table Major Buyers of Human Vaccines
Table Distributors/Traders List
Figure Global Human Vaccines Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Human Vaccines Price (Million USD) and Trend Forecast (2017-2022)
Table Global Human Vaccines Production (K Units) Forecast by Region (2017-2022)
Figure Global Human Vaccines Production Market Share Forecast by Region (2017-2022)
Table Global Human Vaccines Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Human Vaccines Consumption Market Share Forecast by Region (2017-2022)
Figure North America Human Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Human Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Human Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Human Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Human Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Human Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Human Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Human Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Human Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Human Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Human Vaccines Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Human Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Human Vaccines Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Human Vaccines Production (K Units) Forecast by Type (2017-2022)
Figure Global Human Vaccines Production (K Units) Forecast by Type (2017-2022)
Table Global Human Vaccines Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Human Vaccines Revenue Market Share Forecast by Type (2017-2022)
Table Global Human Vaccines Price Forecast by Type (2017-2022)
Table Global Human Vaccines Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Human Vaccines Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ヒトワクチンの世界市場] (Global Human Vaccines Market Research Report 2017 / QYR70902629)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆